A detailed history of Parallel Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Parallel Advisors, LLC holds 5,575 shares of TAK stock, worth $77,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,575
Previous 6,469 13.82%
Holding current value
$77,213
Previous $89,000 19.1%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$12.6 - $13.67 $11,264 - $12,220
-894 Reduced 13.82%
5,575 $72,000
Q1 2024

May 06, 2024

BUY
$13.89 - $15.04 $15,126 - $16,378
1,089 Added 20.24%
6,469 $89,000
Q4 2023

Feb 09, 2024

SELL
$13.36 - $15.43 $23,780 - $27,465
-1,780 Reduced 24.86%
5,380 $76,000
Q3 2023

May 20, 2024

BUY
$15.03 - $16.32 $8,296 - $9,008
552 Added 8.35%
7,160 $110,000
Q3 2023

Nov 13, 2023

BUY
$15.03 - $16.32 $8,296 - $9,008
552 Added 8.35%
7,160 $110,000
Q2 2023

May 20, 2024

BUY
$15.57 - $17.11 $23,868 - $26,229
1,533 Added 30.21%
6,608 $103,000
Q2 2023

Aug 04, 2023

BUY
$15.57 - $17.11 $23,868 - $26,229
1,533 Added 30.21%
6,608 $103,000
Q1 2023

May 20, 2024

SELL
$15.28 - $16.48 $21,300 - $22,973
-1,394 Reduced 21.55%
5,075 $83,000
Q1 2023

Apr 25, 2023

BUY
$15.28 - $16.48 $24,799 - $26,747
1,623 Added 47.02%
5,075 $83,000
Q4 2022

Feb 03, 2023

SELL
$12.42 - $15.62 $98,167 - $123,460
-7,904 Reduced 69.6%
3,452 $53,000
Q3 2022

Nov 10, 2022

BUY
$12.8 - $28.65 $8,192 - $18,336
640 Added 5.97%
11,356 $147,000
Q2 2022

Aug 01, 2022

BUY
$13.12 - $15.03 $8,449 - $9,679
644 Added 6.39%
10,716 $150,000
Q1 2022

Apr 28, 2022

BUY
$13.54 - $15.35 $38,142 - $43,240
2,817 Added 38.83%
10,072 $145,000
Q4 2021

Jan 20, 2022

BUY
$13.17 - $16.4 $17,674 - $22,008
1,342 Added 22.7%
7,255 $99,000
Q3 2021

Nov 02, 2021

BUY
$16.3 - $17.26 $22,445 - $23,767
1,377 Added 30.36%
5,913 $97,000
Q2 2021

Aug 06, 2021

SELL
$16.55 - $18.64 $3,674 - $4,138
-222 Reduced 4.67%
4,536 $76,000
Q1 2021

Apr 23, 2021

BUY
$16.71 - $19.9 $15,941 - $18,984
954 Added 25.08%
4,758 $87,000
Q4 2020

Feb 02, 2021

SELL
$15.39 - $18.97 $9,187 - $11,325
-597 Reduced 13.57%
3,804 $69,000
Q3 2020

Oct 27, 2020

SELL
$17.1 - $19.19 $1,932 - $2,168
-113 Reduced 2.5%
4,401 $79,000
Q2 2020

Jul 16, 2020

BUY
$14.59 - $19.5 $29,311 - $39,175
2,009 Added 80.2%
4,514 $80,000
Q1 2020

Apr 27, 2020

BUY
$13.02 - $20.31 $7,056 - $11,008
542 Added 27.61%
2,505 $38,000
Q4 2019

Jan 30, 2020

BUY
$16.88 - $20.83 $7,663 - $9,456
454 Added 30.09%
1,963 $39,000
Q3 2019

Nov 01, 2019

BUY
$16.15 - $17.99 $17,894 - $19,932
1,108 Added 276.31%
1,509 $26,000
Q2 2019

Aug 05, 2019

SELL
$16.58 - $20.49 $20,260 - $25,038
-1,222 Reduced 75.29%
401 $7,000
Q1 2019

May 01, 2019

BUY
$16.7 - $21.52 $27,104 - $34,926
1,623 New
1,623 $33,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.